Contact
searchSearch
HMP Global

Advertisement

ADVERTISEMENT

Insights

Ann Latner Headshot
Commentary
Alabama Pharmacy Liable for $110,000 Penalty for Recordkeeping Violations
05/17/2024
Ann Latner, JD
“Prescription medications, when misused, can pose a grave threat to public health,” said Acting Special Agent in Charge Steven L. Hofer of the DEA. “That’s why meticulous recordkeeping by pharmacies is an essential line of defense against the...
“Prescription medications, when misused, can pose a grave threat to public health,” said Acting Special Agent in Charge Steven L. Hofer of the DEA. “That’s why meticulous recordkeeping by pharmacies is an essential line of defense against the...
“Prescription medications, when...
05/17/2024
Pharmacy Learning Network
Jennings Headshot
Talking Therapeutics
Another Dangerous DOAC Drug Interaction
05/09/2024
Douglas L. Jennings, PharmD, FACC, FAHA, FCCP, FHFSA, BCPS
In this installment of Talking Therapeutics, Dr Jennings explores another potentially dangerous direct-acting oral anticoagulant (DOAC) combination based on a recent study.
In this installment of Talking Therapeutics, Dr Jennings explores another potentially dangerous direct-acting oral anticoagulant (DOAC) combination based on a recent study.
In this installment of Talking...
05/09/2024
Pharmacy Learning Network
Ann Headshot
Commentary
Walgreens and Philadelphia Settle Opioid Lawsuit for $110 Million
05/06/2024
Ann Latner, JD
The City of Philadelphia has announced it has reached a settlement with Walgreens over a 2021 lawsuit alleging that the drug store perpetuated the opioid crisis in the Pennsylvania city.
The City of Philadelphia has announced it has reached a settlement with Walgreens over a 2021 lawsuit alleging that the drug store perpetuated the opioid crisis in the Pennsylvania city.
The City of Philadelphia has...
05/06/2024
Pharmacy Learning Network

Advertisement

Talking Therapeutics
Advancing Decongestive Strategies in Acute Heart Failure
04/25/2024
Douglas L. Jennings, PharmD, FACC, FAHA, FCCP, FHFSA, BCPS
In this installment of Talking Therapeutics, Dr Jennings analyzes recent study findings determining efficacy of dapagliflozin in patients with acute heart failure.
In this installment of Talking Therapeutics, Dr Jennings analyzes recent study findings determining efficacy of dapagliflozin in patients with acute heart failure.
In this installment of Talking...
04/25/2024
Pharmacy Learning Network
Ann Latner Headshot
Commentary
NY Issues Standing Order for Pharmacists to Provide Hormonal Contraception
04/25/2024
Ann Latner, JD
In mid-March 2024, New York Governor Kathy Hochul signed a standing order allowing pharmacists to dispense 3 types of hormonal contraception–oral hormonal pill, hormonal vaginal ring, and the contraceptive patch–without a prescription.
In mid-March 2024, New York Governor Kathy Hochul signed a standing order allowing pharmacists to dispense 3 types of hormonal contraception–oral hormonal pill, hormonal vaginal ring, and the contraceptive patch–without a prescription.
In mid-March 2024, New York...
04/25/2024
Pharmacy Learning Network
Commentary
First Nonprescription Continuous Glucose Monitor: Will it Expand Diabetes Care Access?
04/22/2024
Yvette C Terrie, BS Pharm, RPh, consultant pharmacist
The recent FDA approval of the Dexcom Stelo Glucose Biosensor System marks the first over-the-counter (OTC) continuous glucose monitoring (CGM) device, aimed at individuals 18 years and older not using insulin.
The recent FDA approval of the Dexcom Stelo Glucose Biosensor System marks the first over-the-counter (OTC) continuous glucose monitoring (CGM) device, aimed at individuals 18 years and older not using insulin.
The recent FDA approval of the...
04/22/2024
Pharmacy Learning Network

Advertisement

Ann Latner Headshot
Commentary
MN Pharmacist Discriminated by Not Filling Emergency Contraception Rx
04/11/2024
Ann Latner, JD
In a first-of-its-kind, historic decision, the Minnesota Court of Appeals has held that it is illegal sex discrimination under the Minnesota Human Rights Act for a pharmacist to refuse to fill a legitimate prescription for emergency...
In a first-of-its-kind, historic decision, the Minnesota Court of Appeals has held that it is illegal sex discrimination under the Minnesota Human Rights Act for a pharmacist to refuse to fill a legitimate prescription for emergency...
In a first-of-its-kind, historic...
04/11/2024
Pharmacy Learning Network
Jennings Headshot
Talking Therapeutics
Strong Evidence for Harm When Combining SSRIs and Blood Thinners
04/09/2024
Douglas L. Jennings, PharmD, FACC, FAHA, FCCP, FHFSA, BCPS
In this installment of Talking Therapeutics, Dr Jennings discusses the risks associated with combining selective serotonin inhibitors (SSRIs) and blood thinners.
In this installment of Talking Therapeutics, Dr Jennings discusses the risks associated with combining selective serotonin inhibitors (SSRIs) and blood thinners.
In this installment of Talking...
04/09/2024
Pharmacy Learning Network
Ann Latner Headshot
Commentary
Federal Appeals Court Revives VA Pharmacist’s Gender Discrimination Claim
04/09/2024
Ann Latner, JD
The United States Court of Appeals for the Federal Circuit has just revived the case of a female pharmacist who claimed gender discrimination after a male pharmacist was hired at a higher pay.
The United States Court of Appeals for the Federal Circuit has just revived the case of a female pharmacist who claimed gender discrimination after a male pharmacist was hired at a higher pay.
The United States Court of...
04/09/2024
Pharmacy Learning Network

Advertisement

Jennings Headshot
Talking Therapeutics
Contraindications Associated With Combining Amiodarone and Rivaroxaban
04/08/2024
Douglas L. Jennings, PharmD, FACC, FAHA, FCCP, FHFSA, BCPS
In this installment of Talking Therapeutics, Dr Jennings examines the interactions between amiodarone and rivaroxaban for patients under prescription, outlining crucial considerations for prescribers when administering these medications to...
In this installment of Talking Therapeutics, Dr Jennings examines the interactions between amiodarone and rivaroxaban for patients under prescription, outlining crucial considerations for prescribers when administering these medications to...
In this installment of Talking...
04/08/2024
Pharmacy Learning Network

Advertisement

Advertisement

Stay Informed & Sign Up Today

Pharmacy Learning Network Newsletter

Advertisement

Video Insights

Videos
David Rubin, MD, on JAK Inhibitors: Small But Mighty
11/22/2023

Featuring David Rubin, MD

Featuring David Rubin, MD
Dr Rubin reviews his presentation from the Advances in Inflammatory Bowel Disease regional meeting on the latest information on the safety and efficacy of Janus kinase inhibitors for the treatment of inflammatory bowel disease.
Dr Rubin reviews his presentation from the Advances in Inflammatory Bowel Disease regional meeting on the latest information on the safety and efficacy of Janus kinase inhibitors for the treatment of inflammatory bowel disease.
Dr Rubin reviews his...
11/22/2023
Pharmacy Learning Network
Videos
Advantages and Drawbacks of Lecanemab in Alzheimer Disease Treatment
11/10/2023

Featuring Paul Schulz, MD 

Featuring Paul Schulz, MD 
Dr Shulz discusses the FDA-approved lecanemab for the treatment of AD.
Dr Shulz discusses the FDA-approved lecanemab for the treatment of AD.
Dr Shulz discusses the...
11/10/2023
Pharmacy Learning Network
Videos
Immunosuppressants or Immunomodulators? Biologic Agents for Psoriasis
10/27/2023

Featuring Ronald Vender, MD, FRCPC

Featuring Ronald Vender, MD, FRCPC ...
In this exclusive interview, Dr Ronald Vender goes over the highly effective targeted biologic therapies used to treat psoriasis.
In this exclusive interview, Dr Ronald Vender goes over the highly effective targeted biologic therapies used to treat psoriasis.
In this exclusive interview, Dr...
10/27/2023
Pharmacy Learning Network
Videos
Application of Dupilumab to Pediatric Patients With Atopic Dermatitis
10/27/2023

Featuring Abigail Cline, MD, PhD, FAAD

Featuring Abigail Cline, MD, PhD, FAA...
In this feature video, Dr Abigail Cline discusses current literature to assess reported efficacies, side effects, and risks of using dupilumab to treat atopic dermatitis in pediatric patients.
In this feature video, Dr Abigail Cline discusses current literature to assess reported efficacies, side effects, and risks of using dupilumab to treat atopic dermatitis in pediatric patients.
In this feature video, Dr...
10/27/2023
Pharmacy Learning Network
Videos
Patient Considerations When Prescribing Lecanemab for Alzheimer Disease
10/06/2023

Featuring Paul Schulz, MD

Featuring Paul Schulz, MD
Dr Paul Schulz discusses the newly FDA-approved lecanemab for the treatment of AD.
Dr Paul Schulz discusses the newly FDA-approved lecanemab for the treatment of AD.
Dr Paul Schulz discusses the...
10/06/2023
Pharmacy Learning Network
Headshots of Chris Fausel, PharmD, MHA, BCOP; Erin Hamai Tom, PharmD, APh, MBA, BCACP; and Ryan Nix, PharmD, MMHC
Videos
Specialty Pharmacy Next: Focus on Distribution Processes, Data Utilization, New Drugs, and More
07/18/2023

Featuring Chris Fausel, PharmD, MHA, BCOP; Erin Hamai Tom, PharmD, APh, MBA, BCACP; and Ryan Nix, PharmD, MMHC

Featuring Chris Fausel, PharmD, MHA, ...
In this roundtable, cochairs of Specialty Pharmacy Next gather to discuss pertinent topics on the agenda such as white and brown bagging practices and data usage for program growth, as well as who may benefit most from attending the meeting.
In this roundtable, cochairs of Specialty Pharmacy Next gather to discuss pertinent topics on the agenda such as white and brown bagging practices and data usage for program growth, as well as who may benefit most from attending the meeting.
In this roundtable, cochairs of...
07/18/2023
Pharmacy Learning Network
Videos
Leaders in Pharmacy Come Together to Discuss and Debate Oncology-Related Developments
06/28/2021
Julie Gould
Chris Fausel, PharmD, Val Adams, PharmD, Kirollos Hanna, PharmD, and Lisa Holle, PharmD, cochairs of Great Debates and Updates Oncology Pharmacy, come together to discuss this new CPE event aimed at educating pharmacists interested in...
Chris Fausel, PharmD, Val Adams, PharmD, Kirollos Hanna, PharmD, and Lisa Holle, PharmD, cochairs of Great Debates and Updates Oncology Pharmacy, come together to discuss this new CPE event aimed at educating pharmacists interested in...
Chris Fausel, PharmD, Val Adams,...
06/28/2021
Pharmacy Learning Network
Expanded FDA Approval Improves Care Access, Rates of Flu Cases
Videos
Expanded FDA Approval Improves Care Access, Rates of Flu Cases
04/19/2021
Gregg Sylvester, MD, MPH, chief medical officer, and David Ross, vice president, commercial operations for North America, both at Seqirus, discuss the recent FDA approval for Flucelvax Quadrivalent, explain what the expanded indication means...
Gregg Sylvester, MD, MPH, chief medical officer, and David Ross, vice president, commercial operations for North America, both at Seqirus, discuss the recent FDA approval for Flucelvax Quadrivalent, explain what the expanded indication means...
Gregg Sylvester, MD, MPH, chief...
04/19/2021
Pharmacy Learning Network
Identifying Drug Diversion Differences in Retail Pharmacies Compared With Health Systems
Videos
Identifying Drug Diversion Differences in Retail Pharmacies Compared With Health Systems
12/28/2020
Tom Knight, founder and CEO, Invistics, identifies drug diversion differences in a hospital or health system versus a retail pharmacy, and explains what retail pharmacies can do to better detect and address drug diversion.
Tom Knight, founder and CEO, Invistics, identifies drug diversion differences in a hospital or health system versus a retail pharmacy, and explains what retail pharmacies can do to better detect and address drug diversion.
Tom Knight, founder and CEO,...
12/28/2020
Pharmacy Learning Network
Identifying Risks of Human Error, Workarounds in Pharmacy
Videos
Identifying Risks of Human Error, Workarounds in Pharmacy
12/22/2020
Matthew Grissinger, RPh, FISMP, FASCP, director of Error Reporting Programs, Institute for Safe Medication Practices, discusses how human error, various at-risk behaviors, as well as workarounds taken by staff members all impact outcomes and...
Matthew Grissinger, RPh, FISMP, FASCP, director of Error Reporting Programs, Institute for Safe Medication Practices, discusses how human error, various at-risk behaviors, as well as workarounds taken by staff members all impact outcomes and...
Matthew Grissinger, RPh, FISMP,...
12/22/2020
Pharmacy Learning Network

Advertisement

Advertisement

Specialties

Events

Year Round Education

HMP Global Products

HMP Education Logo
HMP Omnimedia Logo
HMP Europe Logo
© 2024 HMP Global. All Rights Reserved.
Privacy Policy Terms of Use